Marker Therapeutics, Inc.MRKRNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
29.29%
↓ 91% below average
Average (9y)
319.18%
Historical baseline
Range
High:2261.42%
Low:-89.71%
CAGR
-30.8%
Structural decline
| Period | Value |
|---|---|
| 2024 | 29.29% |
| 2023 | -12.96% |
| 2022 | -56.94% |
| 2021 | 47.21% |
| 2020 | 47.91% |
| 2019 | -89.71% |
| 2018 | 2261.42% |
| 2017 | 38.18% |
| 2016 | 122.09% |
| 2015 | 805.29% |